10x Genomics, Inc.
NASDAQ: TXG0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Serge Saxonov
- Employees
- 1,306
- Headquarters
- Pleasanton, United States
- IPO year
- 2019
- Market cap
- $4.4B
- Website
- https://www.10xgenomics.com
Loading TXG…
Loading profile data…Frequently asked questions about TXG
What does 10x Genomics, Inc. (TXG) do?
Headquartered in Pleasanton, California, 10x Genomics, Inc. (founded in 2012 and known as 10X Technologies, Inc. until November 2014) is a prominent life science technology company. The firm specializes in creating and distributing sophisticated instrumentation, essential consumables, and software designed for in-depth analysis of biological sys...
Where does TXG trade?
10x Genomics, Inc. (TXG) trades on the NASDAQ Global Select.
What sector is TXG in?
10x Genomics, Inc. (TXG) operates in the Healthcare sector, specifically in the Medical - Healthcare Information Services industry.
Who is the CEO of 10x Genomics, Inc.?
Serge Saxonov is the chief executive officer of 10x Genomics, Inc. (TXG).
Where is 10x Genomics, Inc. headquartered?
10x Genomics, Inc. is headquartered in United States.
Does TXG pay a dividend?
10x Genomics, Inc. (TXG) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TXG go public?
10x Genomics, Inc. (TXG) completed its initial public offering in 2019.